COHR completes Three Cities deal
Independent service organization COHR of Chatsworth, CA, went private this month when it closed a deal to be acquired by investment advisor firm Three Cities Research of New York City. Three Cities paid $6.50 in cash for each of COHR’s outstanding
Independent service organization COHR of Chatsworth, CA, went private this month when it closed a deal to be acquired by investment advisor firm Three Cities Research of New York City. Three Cities paid $6.50 in cash for each of COHRs outstanding shares.
TCR initiated the deal in December when it bought a 48% interest in COHR from Franklin Research of San Mateo, CA, and Strong Capital Management of Milwaukee (SCAN 1/13/99). The deal gives COHR relief from conducting its business under public scrutiny, but otherwise COHRs operations should not change as a result of the merger, according to company executives.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
